
Grifols completes development of molecular test to detect SARS-CoV-2 virus
Catalan Economy
06 May 2020
“Having sufficient molecular test capacity is critical to helping control this pandemic, and having a high-sensitivity test to handle a possible ‘pooling’ strategy is, without a doubt, a differentiating factor, which could make it feasible,” said Victor Grifols Deu, Grifols co-CEO in the company’s press release.
Grifols began developing its test to detect SARS-CoV-2 the first week of February, through its teams in San Diego, Bilbao and Barcelona.
Source: Grifols
Related News and Success stories.
-
19 Jun 2025
Mobile World Congress 2025 generated €561 million economic impact to Barcelona
-
11 Jun 2025
Barcelona-based SpliceBio secures a €118 million financing round for advancing in gene therapy
-
11 Jun 2025
Catalonia targets Asian markets with first wine trade mission to China and Taiwan
-
06 Jun 2025
Barcelona chosen as UNESCO's global hub for the sustainable Blue Economy